YU56696A - Polimorfni oblici agensa koji potpomaže izlučivanje hormona rasta - Google Patents

Polimorfni oblici agensa koji potpomaže izlučivanje hormona rasta

Info

Publication number
YU56696A
YU56696A YU56696A YU56696A YU56696A YU 56696 A YU56696 A YU 56696A YU 56696 A YU56696 A YU 56696A YU 56696 A YU56696 A YU 56696A YU 56696 A YU56696 A YU 56696A
Authority
YU
Yugoslavia
Prior art keywords
polymorphic forms
growth hormone
secretagogue
phenylmethyloxy
indole
Prior art date
Application number
YU56696A
Other languages
English (en)
Serbo-Croatian (sh)
Inventor
Jerome P. Draper
David C. Dubost
Michael J. Kaufman
James A. Mccauley
Jennnifer L. Vandrilla
Richard J. Varsolona
Original Assignee
Merck & Co. Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9603361.8A external-priority patent/GB9603361D0/en
Application filed by Merck & Co. Inc. filed Critical Merck & Co. Inc.
Publication of YU56696A publication Critical patent/YU56696A/sh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Fodder In General (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
YU56696A 1995-10-27 1996-10-25 Polimorfni oblici agensa koji potpomaže izlučivanje hormona rasta YU56696A (sh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US590095P 1995-10-27 1995-10-27
GBGB9603361.8A GB9603361D0 (en) 1996-02-16 1996-02-16 Polymorphic forms of a growth hormone secretagogue

Publications (1)

Publication Number Publication Date
YU56696A true YU56696A (sh) 1999-09-27

Family

ID=26308741

Family Applications (1)

Application Number Title Priority Date Filing Date
YU56696A YU56696A (sh) 1995-10-27 1996-10-25 Polimorfni oblici agensa koji potpomaže izlučivanje hormona rasta

Country Status (22)

Country Link
EP (1) EP1019402A1 (xx)
JP (1) JP3204266B2 (xx)
KR (1) KR19990067098A (xx)
CN (1) CN1067687C (xx)
AU (1) AU707946B2 (xx)
BG (1) BG102476A (xx)
BR (1) BR9611229A (xx)
CA (1) CA2235371A1 (xx)
CO (1) CO4770956A1 (xx)
CZ (1) CZ128098A3 (xx)
EA (1) EA000528B1 (xx)
EE (1) EE9800147A (xx)
HK (1) HK1017894A1 (xx)
HU (1) HUP9902208A3 (xx)
IS (1) IS4721A (xx)
NO (1) NO310556B1 (xx)
NZ (1) NZ321370A (xx)
PL (1) PL327511A1 (xx)
SK (1) SK51398A3 (xx)
TR (1) TR199800726T2 (xx)
WO (1) WO1997015574A1 (xx)
YU (1) YU56696A (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6046333A (en) * 1996-10-25 2000-04-04 Merck & Co., Inc. Convergent process for the preparation of a growth hormone secretagogue
US9119832B2 (en) 2014-02-05 2015-09-01 The Regents Of The University Of California Methods of treating mild brain injury
US20170121385A1 (en) 2015-10-28 2017-05-04 Oxeia Biopharmaceuticals, Inc. Methods of treating neurodegenerative conditions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2168512C2 (ru) * 1992-12-11 2001-06-10 Мерк Энд Ко., Инк. Спиропиперидины, способы их получения (варианты)

Also Published As

Publication number Publication date
NZ321370A (en) 1999-11-29
PL327511A1 (en) 1998-12-21
NO981867L (no) 1998-06-29
CN1205703A (zh) 1999-01-20
EA000528B1 (ru) 1999-10-28
JP3204266B2 (ja) 2001-09-04
SK51398A3 (en) 1998-12-02
BR9611229A (pt) 1999-05-25
AU707946B2 (en) 1999-07-22
EP1019402A1 (en) 2000-07-19
BG102476A (en) 1999-04-30
AU7468696A (en) 1997-05-15
EA199800335A1 (ru) 1998-12-24
CO4770956A1 (es) 1999-04-30
JPH10512295A (ja) 1998-11-24
MX9803351A (es) 1998-09-30
NO310556B1 (no) 2001-07-23
NO981867D0 (no) 1998-04-24
CZ128098A3 (cs) 1998-09-16
CA2235371A1 (en) 1997-05-01
HK1017894A1 (en) 1999-12-03
EE9800147A (et) 1998-12-15
WO1997015574A1 (en) 1997-05-01
KR19990067098A (ko) 1999-08-16
HUP9902208A2 (hu) 1999-10-28
CN1067687C (zh) 2001-06-27
TR199800726T2 (xx) 1998-08-21
IS4721A (is) 1998-04-21
HUP9902208A3 (en) 2001-05-28

Similar Documents

Publication Publication Date Title
DK339289D0 (da) Farmaceutisk praeparat
DE3369851D1 (en) Derivatives of amides of carboxylic acids in which the n atom is substituted by a glycosyl radical, method for their preparation and their use to influence the immunogenic system
AR012255A1 (es) Sal tartrato de un dipeptido sustituido
IT8149523A0 (it) Procedimento per il trattamento di noci nocelle mandorle e simili per ridurne il contenuto di grassi e preservarne l'aroma naturale
Kesner et al. Effects of electrical stimulation of amygdala upon neophobia and taste aversion
DE29622959U1 (de) Analoge des Lachs-Calcitonin
DE3175580D1 (en) Method for enhancing the growth rate of meat-producing animals and for improving the lean meat to fat ratio thereof
DE69632396D1 (de) Behandlung von erkrankungen, die vom cytokinwachstumsfaktor verursacht werden
RU2711298C2 (ru) Композиция для предотвращения или лечения выпадения волос, содержащая белок хемокинового лиганда 1, содержащего с-х-с мотив (cxcli)
ES439803A1 (es) Un procedimiento para la preparacion de aminas.
DE60135904D1 (de) Arzneien zur behandlung von nervenerkrankungen
YU56696A (sh) Polimorfni oblici agensa koji potpomaže izlučivanje hormona rasta
YU56596A (sh) Postupak za dobijanje agensa koji potpomaže izlučivanje hormona rasta
HUT57204A (en) Process for producing 4-fluoro-2-///4-methoxy-2-pyridinyl/-methyl/-sulfinyl/-1h-benzimidazol with gastric acid secration-diminishing activity and pharmaceutical compositions containing them
FR2633619B1 (fr) Nouveau sel de strontium, son procede de preparation et les compositions pharmaceutiques le renfermant
MXPA04007556A (es) Estimulacion de cpt-1 como medio para reducir peso.
Jahnsen et al. An acceptability study of two pivampicillin mixtures in children in general practice
Shimizu et al. Stimulation of the cell-free adenylate cyclase from guinea pig cerebral cortex by acidic amino acids and veratridine
Lao et al. Electroacupuncture reduces morphine-induced emesis in ferrets: a pilot study
HUP0002643A2 (hu) Szívrendellenességek kezelése és megelőzése SSRI-k alkalmazásával
HUT57040A (en) Process for producing pharmaceutical compositions comprising 2-brackets open 4-(4-chlorophenyl)-cyclohexyl brackets closed-3-hydroxy-1,4-naphthoquinone suitable for treating toxoplasmosis
IL95892A0 (en) Aroyl-ureas,their preparation and pharmaceutical compositions containing them
Targum et al. The TRH test and thyroid hormone in refractory depression.
JP2001354522A (ja) アスコルビン酸誘導体を含有する育毛剤
HUT60431A (en) Process for producing pharmaceutical compositions comprising naphthoquinone derivative and suitable for treating cryptosporidiosis